IP21-15 SMART TRIAL: A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL COMPARING THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER BY MRI-TARGETED APPROACH VERSUS 24-CORE TRANSPERINEAL SYSTEMATIC BIOPSY

Peter Ka‐Fung Chiu, Weiling Yu, Wilson H. C. Chan, Cedric L. F. Lee, Brian Ho, Dedkov Ip, Jeffrey Yu, Francis C. H. Wong, Julius H. F. Wong, Ka-Lun Lo, Clarence Leung, Christy Wing–Hin Mak, Andrew Tam, Wayne Lam, Sze-Wan Kwok, Cindy Hong, Angel W. Y. Kong, Chi-Hang Samuel, Jeremy Yuen‐Chun Teoh, Chi‐Fai Ng, Scientific Esc Document Group.The Journal of Urology 2025 · DOI

BibTeX
@article{chiu2025ip,
  author = {Peter Ka‐Fung Chiu and Weiling Yu and Wilson H. C. Chan and Cedric L. F. Lee and Brian Ho and Dedkov Ip and Jeffrey Yu and Francis C. H. Wong and Julius H. F. Wong and Ka-Lun Lo and Clarence Leung and Christy Wing–Hin Mak and Andrew Tam and Wayne Lam and Sze-Wan Kwok and Cindy Hong and Angel W. Y. Kong and Chi-Hang Samuel and Jeremy Yuen‐Chun Teoh and Chi‐Fai Ng and Scientific ESC Document Group.},
  title = {{IP21-15 SMART TRIAL: A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL COMPARING THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER BY MRI-TARGETED APPROACH VERSUS 24-CORE TRANSPERINEAL SYSTEMATIC BIOPSY}},
  journal = {The Journal of Urology},
  year = {2025},
  doi = {10.1097/01.ju.0001110100.38838.c8.15},
}

Loading related content...

Figure